Endometrics
PrivateLast Round
Grant
Mar 21, 2026
Total Funding Raised
$1.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Endometrics is a molecular diagnostics company that develops a non-invasive diagnostic test for endometriosis using a menstrual blood sample.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endometrics Comparables
Compare Endometrics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nura Health | 90% | |
| NextGen Jane | 87% | |
| EndoSure, Inc. | 87% |
Endometrics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 21, 2026 | ||||
| Accelerator | Feb 12, 2026 | ||||
| Pre Seed | Mar 3, 2023 | ||||
| Accelerator | Sep 26, 2022 |
Endometrics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Granatus Ventures | Pre Seed |
| NIH RADx | Grant |
| Supernode Ventures | Pre Seed |
| First Spark Ventures | Pre Seed |
| MassChallenge Israel | Accelerator |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 69% MoM, from 1.2K to 2K.
- Mar 21, 2026
$950K awarded by two national institutes.
Endometrics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endometrics's valuation, stock price, and market status.
Is Endometrics a public or private company?
Endometrics is a private company.
What is the current stock price of Endometrics?
Endometrics is a private company, so its shares have no public market price. Caplight tracks Endometrics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endometrics worth (valuation)?
Valuation information for Endometrics is not publicly available.
Can I buy Endometrics stock?
Endometrics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endometrics's last funding round?
Endometrics's most recent funding round was Grant on March 21, 2026.
Who are the main investors in Endometrics?
Key investors in Endometrics include National Institute of Biomedical Imaging and Bioengineering, Granatus Ventures, NIH RADx, Supernode Ventures, First Spark Ventures.
Will Endometrics IPO soon?
No public IPO plans have been announced for Endometrics.
How can I track Endometrics secondary market activity?
Caplight tracks bids, offers, and trades in Endometrics's shares on secondary markets.